SKAN
Les Edwards has a strong background in the pharmaceutical and medical device industries. Les started their career at Penn Medicine as a Clinical Engineer from 1986 to 1990. Les then worked at Merck & Co., Inc. as a Consulting Engineer in Sterile Process Engineering in 1994. In 1995, Les became a Partner at Advanced Barrier Concepts, Inc. and continued in that role until 2004. Les then joined Advanced Barrier Process, LLC as the President from 2005 to 2008. Following that, Les served as the CEO of Isogen, LLC from 2008 to 2009. From 2010 to 2011, they worked as a Consultant at Hanscome Validation and Consulting, LLC, providing technical leadership to pharmaceutical and medical device companies. Most recently, they have been working at SKAN US, Inc., starting as the Regional Director from 2011 to 2016, and currently holding the position of Vice President, Technology and Business Development.
Les Edwards received a BSE degree in Bioengineering and Biomedical Engineering from the University of Pennsylvania from 1982 to 1986. Later, they pursued an MSE degree in Business, Bioengineering, and Technology Management from the same university from 1988 to 1990.
This person is not in any offices
SKAN
1 followers
SKAN is a Swiss company and a global market and technological leader for isolators, cleanroom devices, and decontamination processes for the aseptic production of biopharmaceutical substances. SKAN's core competency is the design and development of process isolators for the aseptic filling of biopharmaceutical products. Furthermore, the company offers its customers process support, services, and consumables. SKAN's technology and innovation leadership is based on a unique combination of specialist knowledge in the areas of ventilation technology, air conditioning, sterilisation, software programming that must be validated in a pharmaceutically compliant manner, microbiology and chemistry. It is also experienced when it comes to regulatory requirements and production competency. With its state-of-the-art products and services, SKAN focusses on markets with the highest regulatory requirements in the health sector. These are mainly situated in Europe, North America, Japan, South Korea, and Singapore. SKAN's expertise and innovative energy is the result of long years of trusting relationships with blue-chip (bio)pharmaceutical companies and leading research laboratories worldwide. SKAN's products and services are decisive for the success of its customers. For this reason, the company profits from high market entry barriers. Thanks to the experts at our in-house laboratories who research innovative solutions for isolator technology, SKAN can fulfill even the most complex customer requirements. Data Protection Declaration: https://skan.com/en/data-protection-declaration/ Legal notice: https://skan.com/en/legal-notice/